Visualase uses light energy to destroy unwanted tissue. Laser-induced interstitial thermotherapy (LITT) is one of the most recent developments in laser therapy. In this treatment, laser fibers are directed to targeted areas in the body, often tumor tissue. Laser light is delivered through the probe which raises the temperature of the target tissue, irreversibly destroying the targeted tissue. As more surgeons become trained on the Visualase technology, lasers may have an increased impact on many types of tumor treatment. Doctors are currently treating patients for brain cancer, epilepsy, prostate cancer, and studying other applications for bone and spinal cancer, liver cancer, thyroid cancer, and other thermal tumor ablation.

Our goal is to provide physicians with a superior platform for minimally invasive thermal tumor therapy and merge existing diagnostic and therapeutic environments for improved patient care.

Visualase utilizes laser-induced interstitial thermal therapy (LITT), a minimally invasive therapy in combination with a powerful image-guided system (MR, MRI) to localize heat to a target and to visualize thermal therapy in real time. LITT, or Laser-Induced Interstitial Thermotherapy, is a treatment option for many types of both benign and malignant tumors, including primary gliomas and other brain masses. LITT – also referred to as laser interstitial thermal therapy, laser-induced thermotherapy, interstitial laser therapy, laser ablation or laser thermal ablation – is a surgical procedure in which destruction of soft tissues in the body is effected through high temperatures generated by the local absorption of laser energy.